5 High-Flying Large-Cap Stocks to Buy Amid Tariff-Led Market RoutZacks Investment Research • 04/09/25
This Insulin Pump Maker Expands Into New Territory And Its Stock Shows Relative StrengthInvestors Business Daily • 04/07/25
PODD Stock to Gain From Favorable RADIANT Trial Results for Omnipod 5Zacks Investment Research • 03/20/25
Insulet's RADIANT Trial Demonstrates Meaningful Glycemic Improvements with the Omnipod® 5 Automated Insulin Delivery System Following Direct Transition from Multiple Daily InjectionsBusiness Wire • 03/19/25
3 Tariff-Proof Medical Device Stocks to Watch Amid Trump's MAGA SloganZacks Investment Research • 03/19/25
Insulet's Strong Q4 Highlights Surging Omnipod Demand And Growth Potential: AnalystBenzinga • 02/21/25
PODD Stock Falls Despite Q4 Earnings and Revenue Beat, Margins RiseZacks Investment Research • 02/21/25
Compared to Estimates, Insulet (PODD) Q4 Earnings: A Look at Key MetricsZacks Investment Research • 02/20/25
Insulet Reports Full Year 2024 Revenue Increase of 22% and Fourth Quarter 2024 Revenue Increase of 17% Year-Over-YearBusiness Wire • 02/20/25
Stay Ahead of the Game With Insulet (PODD) Q4 Earnings: Wall Street's Insights on Key MetricsZacks Investment Research • 02/14/25
PODD Stock Gains From the Launch of Omnipod 5 in Five Countries in EUZacks Investment Research • 01/14/25